ESS vs STOK · P/E 31, rev $489.0M vs rev $15.6M
Essex Property Trust Inc (ESS) versus Stoke Therapeutics Inc (STOK) — a side-by-side from cached financials, not a winner call.
Essex Property Trust Inc (ESS) is a reit - residential company listed on NYSE.
Stoke Therapeutics Inc (STOK) is a biotechnology company listed on NASDAQ.
Latest reported ESS revenue for 2026-06-30 was $489.0M. Net income was $66.9M. Revenue was up 0.9% from 2026-03-31 to 2026-06-30. ESS currently screens at market cap $18.91B and trailing P/E 30.9.
Latest reported STOK revenue for 2026-06-30 was $15.6M. Net income was -$111.6M. STOK currently screens at market cap $1.88B.
ESS currently screens at market cap $18.91B and trailing P/E 30.9. STOK currently screens at market cap $1.88B.
Not investment advice. Open the ESS and STOK stock pages for the full models.
Not investment advice.